ACE and diabetes mellitus: Demographic and clinical variables associated with a greater decrease in eGFR and included in the multivariable models were presence of a LVAD prior to transplant (p < 0.001), absence of pre-transplant diabetes (p = 0.033), younger age at transplant (p < 0.001), and not being prescribed an ACE inhibitor or ARB 1-year post-transplant (p = 0.013).